 Indias Sovereign Pharma said it has dispatched the first batch of generic remdesivir for drugmaker Cipla Ltd, as the country recorded more than 22,000 new coronavirus cases on Tuesday. At current capacity, Sovereign can supply 50,000 to 95,000 vials per month of the injectable, the company said in an emailed statement on Tuesday. It did not disclose how many vials are there in the batch for Cipla. 